{"id":2937,"date":"2024-03-25T02:55:43","date_gmt":"2024-03-25T09:55:43","guid":{"rendered":"https:\/\/depts.washington.edu\/tlcart\/?p=2937"},"modified":"2024-03-25T02:55:43","modified_gmt":"2024-03-25T09:55:43","slug":"leap-and-croi-in-denver","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/tlcart\/leap-and-croi-in-denver\/","title":{"rendered":"LEAP and CROI in Denver"},"content":{"rendered":"

Dr. Ho and his team attended and contributed to the LEAP<\/a> workshop and CROI<\/a> in Denver, highlighting their development in Drug-combination nanoparticle technology. This innovative technology simplifies and scales up the formulation of multiple antiretrovirals into a single injectable for long-acting HIV therpay.<\/p>\n

During LEAP, Rodney updated attendees on the project’s progress over the last year. At CROI, their focus was on a poster presentation in the pediatric section, discussing a validated PBPK model for pediatric dosing.<\/p>\n

Key topics at CROI included advancements in HIV vaccines, mAbs, long-acting injectables, and pediatric HIV treatment solutions.<\/p>\n

For further details, contact tlcart@uw.edu<\/a>.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\n
\n
\n